|
|
 |
STARCH, PREGELATINIZED CORN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SUSTOL Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
STEARIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
STRIBILD Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SUPPRELIN LA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|